These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31106725)

  • 21. Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027.
    Pollock NR; Song L; Zhao M; Duffy DC; Chen X; Sambol SP; Gerding DN; Kelly CP
    J Clin Microbiol; 2015 May; 53(5):1705-8. PubMed ID: 25716449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection.
    Alcalá L; Reigadas E; Marín M; Fernández-Chico A; Catalán P; Bouza E
    J Clin Microbiol; 2015 Jan; 53(1):332-5. PubMed ID: 25392360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile colitis: an efficient clinical approach to diagnosis.
    Manabe YC; Vinetz JM; Moore RD; Merz C; Charache P; Bartlett JG
    Ann Intern Med; 1995 Dec; 123(11):835-40. PubMed ID: 7486465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid detection of Clostridium difficile toxins from stool samples using real-time multiplex PCR.
    Pallis A; Jazayeri J; Ward P; Dimovski K; Svobodova S
    J Med Microbiol; 2013 Sep; 62(Pt 9):1350-1356. PubMed ID: 23788597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
    Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of Clostridium difficile in stool using the VIDASR C. difficile Toxin A II assay.
    Lipson SM; Tortora G; Tempone A; Fedorko DP; Spitzer ED
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):117-21. PubMed ID: 12614982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the Bristol Stool Form Chart scoring system for laboratory processing of faecal samples in suspected cases of Clostridioides difficile.
    Gauthier J
    J Hosp Infect; 2020 Aug; 105(4):778. PubMed ID: 32417432
    [No Abstract]   [Full Text] [Related]  

  • 28. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carriers of Clostridioides (Clostridium) difficile: To the Center of Focus for Controlling the Rate of Infection.
    Zervou FN; Zacharioudakis IM; Mylonakis E
    Clin Infect Dis; 2019 Oct; 69(9):1645-1646. PubMed ID: 30901033
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection.
    Jazmati N; Kirpal E; Piepenbrock E; Stelzer Y; Vehreschild MJGT; Seifert H
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 32. Clostridioides difficile Infection.
    Guh AY; Kutty PK
    Ann Intern Med; 2018 Oct; 169(7):ITC49-ITC64. PubMed ID: 30285209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glutamate dehydrogenase. Its diagnostic value in Clostridioides difficile diarrhea].
    Vaustat D; Rollet R
    Rev Argent Microbiol; 2018; 50(3):264-268. PubMed ID: 29150184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
    Hong G; Park KS; Ki CS; Lee NY
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.
    Depitre C; Avesani V; Delmée M; Corthier G
    Gastroenterol Clin Biol; 1993; 17(4):283-6. PubMed ID: 8339887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which specimens should be tested for Clostridium difficile toxin?
    Berrington A; Settle CD
    J Hosp Infect; 2007 Mar; 65(3):280-2. PubMed ID: 17275962
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.